ZA954074B - Acylated aminoalkanimidazoles and -triazoles - Google Patents

Acylated aminoalkanimidazoles and -triazoles

Info

Publication number
ZA954074B
ZA954074B ZA954074A ZA954074A ZA954074B ZA 954074 B ZA954074 B ZA 954074B ZA 954074 A ZA954074 A ZA 954074A ZA 954074 A ZA954074 A ZA 954074A ZA 954074 B ZA954074 B ZA 954074B
Authority
ZA
South Africa
Prior art keywords
triazoles
compounds
aminoalkanimidazoles
acylated
acylated aminoalkanimidazoles
Prior art date
Application number
ZA954074A
Other languages
English (en)
Inventor
Ingeborg Schuster
Helmut Egger
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA954074B publication Critical patent/ZA954074B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Lubricants (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA954074A 1994-05-18 1995-05-18 Acylated aminoalkanimidazoles and -triazoles ZA954074B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9409882A GB9409882D0 (en) 1994-05-18 1994-05-18 Organic compounds

Publications (1)

Publication Number Publication Date
ZA954074B true ZA954074B (en) 1996-11-18

Family

ID=10755289

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA954074A ZA954074B (en) 1994-05-18 1995-05-18 Acylated aminoalkanimidazoles and -triazoles

Country Status (30)

Country Link
US (1) US5622982A (sk)
EP (1) EP0683156B1 (sk)
JP (1) JP2912566B2 (sk)
KR (1) KR100371465B1 (sk)
CN (1) CN1060163C (sk)
AT (1) ATE164576T1 (sk)
AU (1) AU696880B2 (sk)
BR (1) BR9502062A (sk)
CA (1) CA2149459C (sk)
CO (1) CO4290423A1 (sk)
CZ (1) CZ285385B6 (sk)
DE (1) DE69501915T2 (sk)
DK (1) DK0683156T3 (sk)
ES (1) ES2114289T3 (sk)
FI (1) FI112364B (sk)
GB (1) GB9409882D0 (sk)
GR (1) GR3026505T3 (sk)
HK (1) HK1008743A1 (sk)
HU (1) HUT72063A (sk)
IL (1) IL113743A (sk)
MY (1) MY135559A (sk)
NO (1) NO304738B1 (sk)
NZ (1) NZ272129A (sk)
PE (1) PE14896A1 (sk)
PH (1) PH31510A (sk)
RU (1) RU2152933C2 (sk)
SI (1) SI0683156T1 (sk)
SK (1) SK280326B6 (sk)
TW (1) TW351718B (sk)
ZA (1) ZA954074B (sk)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869499A (en) * 1993-07-15 1999-02-09 Pfizer Inc Benzyloxyquinuclidines as substance P antagonists
US6162801A (en) * 1995-11-20 2000-12-19 Kita; Kiyoshi External ophthalmic preparation containing vitamin D
WO1998053806A1 (fr) * 1997-05-26 1998-12-03 New Vision Co., Ltd. Compositions medicinales a administration topique renfermant les vitamines d et les vitamines k
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
TW575562B (en) * 1998-02-19 2004-02-11 Agrevo Uk Ltd Fungicides
CN1114593C (zh) * 1998-05-08 2003-07-16 陶氏益农有限责任公司 2位被取代的吡啶的制备
GB0029524D0 (en) * 2000-12-04 2001-01-17 Univ Sheffield Disease treatment
GB0128415D0 (en) * 2001-11-27 2002-01-16 Univ Sheffield Medicaments
US7429604B2 (en) * 2004-06-15 2008-09-30 Bristol Myers Squibb Company Six-membered heterocycles useful as serine protease inhibitors
WO2006032299A1 (en) * 2004-09-24 2006-03-30 Susanna Miettinen Use of inhibitors of 24-hydroxylase in the treatment of cancer
US20060078494A1 (en) * 2004-09-24 2006-04-13 Sapphire Therapeutics, Inc. Use of inhibitors of 24-hydroxylase in the treatment of cancer
CN104530038A (zh) * 2014-12-10 2015-04-22 沈阳药科大学 酰胺咪唑类衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2041771C3 (de) * 1970-08-22 1979-07-26 Bayer Ag, 5090 Leverkusen derivate
US4191767A (en) * 1977-01-07 1980-03-04 Westwood Pharmaceuticals, Inc. Method for treating fungal infection in mammals with imidazo [1,2-a]quinoxalines
CH655103A5 (de) * 1983-03-11 1986-03-27 Sandoz Ag Azolderivate, verfahren zu ihrer herstellung und ihre verwendung.
CH677925A5 (sk) * 1986-12-03 1991-07-15 Sandoz Ag

Also Published As

Publication number Publication date
FI952383A0 (fi) 1995-05-16
SI0683156T1 (en) 1998-06-30
CA2149459A1 (en) 1995-11-19
CZ285385B6 (cs) 1999-07-14
CN1120039A (zh) 1996-04-10
ATE164576T1 (de) 1998-04-15
MY135559A (en) 2008-05-30
TW351718B (en) 1999-02-01
PH31510A (en) 1998-11-03
IL113743A0 (en) 1995-08-31
AU2008995A (en) 1995-11-23
NO304738B1 (no) 1999-02-08
CA2149459C (en) 2006-09-19
CN1060163C (zh) 2001-01-03
DK0683156T3 (da) 1998-10-19
PE14896A1 (es) 1996-05-09
JPH0853422A (ja) 1996-02-27
NO951944D0 (no) 1995-05-16
SK63595A3 (en) 1995-12-06
NZ272129A (en) 1996-05-28
NO951944L (no) 1995-11-20
ES2114289T3 (es) 1998-05-16
GR3026505T3 (en) 1998-07-31
DE69501915D1 (de) 1998-05-07
HK1008743A1 (en) 1999-05-14
IL113743A (en) 1999-08-17
FI112364B (fi) 2003-11-28
AU696880B2 (en) 1998-09-24
JP2912566B2 (ja) 1999-06-28
US5622982A (en) 1997-04-22
BR9502062A (pt) 1996-04-30
DE69501915T2 (de) 1998-08-27
CO4290423A1 (es) 1996-04-17
HU9501451D0 (en) 1995-06-28
KR100371465B1 (ko) 2003-03-19
EP0683156A1 (en) 1995-11-22
RU2152933C2 (ru) 2000-07-20
HUT72063A (en) 1996-03-28
FI952383A (fi) 1995-11-19
RU95107652A (ru) 1997-03-20
EP0683156B1 (en) 1998-04-01
KR950032147A (ko) 1995-12-20
GB9409882D0 (en) 1994-07-06
SK280326B6 (sk) 1999-11-08
CZ126595A3 (en) 1995-11-15

Similar Documents

Publication Publication Date Title
IL138402A0 (en) Heterocyclically substituted amides used as calpain inhibitors
PL304649A1 (en) Novel derivatives of taxane and pharmaceutical agents
GR3026505T3 (en) Acylated aminoalkanimidazoles and -triazoles.
CA2214131A1 (en) Trisubstituted phenyl derivatives
DE69008142T2 (de) 4-Substituierten Imidazolen zur Senkung des intraokularen Druckes.
DE69229339T2 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
PT626385E (pt) Derivados do tetra-hidropirano
IL105607A0 (en) Heteroatoms-containing tricyclic compounds,their preparation and pharmaceutical compositions containing them
TW221051B (sk)
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
IL88539A0 (en) Azole compounds,their preparation and their use as fungicides
MY133139A (en) N-substituted azabicycloheptane derivatives, their preparation and use